Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02315066
Title Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | FRA


No variant requirements are available.